Ausgabe 3/2023
Diabetes in Heart Failure
Inhalt (15 Artikel)
An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications
Alberto Palazzuoli, Gianluigi Savarese
Prognostic impact of diabetes in chronic and acute heart failure
Stefano Ghio, Valentina Mercurio, Andrea Attanasio, Gaetano Asile, Carlo Gabriele Tocchetti, Stefania Paolillo
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Alberto Palazzuoli, Massimo Iacoviello
Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo
Redefining diabetes mellitus treatments according to different mechanisms beyond hypoglycaemic effect
Savina Nodari, Francesco Fioretti, Francesco Barilla
Diabetes-induced chronic heart failure is due to defects in calcium transporting and regulatory contractile proteins: cellular and molecular evidence
Sunil Rupee, Khemraj Rupee, Ram B. Singh, Carlin Hanoman, Abla Mohammed Ahmed Ismail, Manal Smail, Jaipaul Singh
Impact of diabetes on cardiopulmonary function: the added value of a combined cardiopulmonary and echocardiography stress test
Nicola Riccardo Pugliese, Alessandra Pieroni, Nicolò De Biase, Valerio Di Fiore, Lorenzo Nesti, Piergiuseppe Agostoni, Frank Lloyd Dini
Use of disease-modifying drugs in diabetic patients with heart failure with reduced ejection fraction
Daniele Masarone, Roberta Pacileo, Giuseppe Pacileo
Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti
Diabetes and SGLT2-iss inhibitors in patients with heart failure with preserved or mid-range left ventricular ejection fractions
Andrea Passantino, Caterina Rizzo, Domenico Scrutinio, Alberto Palazzuoli
Effects of SGLT2 inhibitors on cardiac structure and function
Giuseppina Novo, Tommaso Guarino, Daniela Di Lisi, Paolo Biagioli, Erberto Carluccio
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Paolo Severino, Andrea D’Amato, Silvia Prosperi, Bettina Costi, Danilo Angotti, Lucia Ilaria Birtolo, Cristina Chimenti, Carlo Lavalle, Viviana Maestrini, Massimo Mancone, Francesco Fedele
Renal effects of SGLT2 inhibitors in cardiovascular patients with and without chronic kidney disease: focus on heart failure and renal outcomes
Edoardo G. Gronda, Emilio Vanoli, Massimo Iacoviello, Stefano Urbinati, Pasquale Caldarola, Furio Colivicchi, Domenico Gabrielli
Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients
Michele Correale, Olga Lamacchia, Michele Ciccarelli, Giuseppe Dattilo, Lucia Tricarico, Natale Daniele Brunetti
Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension
Federico Luongo, Cristiano Miotti, Gianmarco Scoccia, Silvia Papa, Giovanna Manzi, Nadia Cedrone, Federica Toto, Claudia Malerba, Gennaro Papa, Annalisa Caputo, Giulia Manguso, Francesca Adamo, Dario Vizza Carmine, Roberto Badagliacca